{
  "name": "Semax",
  "category": "peptide",
  "evidenceGrade": "C",
  "riskProfile": "low",
  "description": "A synthetic analogue of ACTH(4-7) developed in Russia, approved for cognitive enhancement and neuroprotection. Enhances BDNF, NGF, and has robust nootropic effects. Extensively studied in Russian clinical settings for stroke recovery and cognitive decline.",
  "mechanisms": [
    "BDNF and NGF upregulation",
    "Dopamine and serotonin modulation",
    "Neuroprotection via anti-inflammatory pathways",
    "Improved cerebral blood flow"
  ],
  "dosage": {
    "standard": "200-600mcg intranasal, 2-3x/day",
    "range": "100-900mcg/day",
    "notes": "Intranasal drops or spray. Approved in Russia and Ukraine. 10-14 day courses typical."
  },
  "keyFindings": [
    "Improved cognitive performance and memory in clinical trials",
    "Accelerated recovery from ischemic stroke in Russian clinical data",
    "Upregulated BDNF expression by 4-8x in animal hippocampus"
  ],
  "interactions": [
    "May interact with stimulants or ADHD medications"
  ],
  "sideEffects": [
    "Nasal irritation",
    "Mild headache",
    "Irritability at high doses"
  ],
  "contraindications": [
    "Acute psychosis",
    "Seizure disorders",
    "Pregnancy"
  ],
  "tags": [
    "peptide",
    "nootropic",
    "neuroprotective",
    "cognitive",
    "russian-research"
  ],
  "estimatedMonthlyCost": {
    "low": 20,
    "mid": 45,
    "high": 90,
    "currency": "USD"
  },
  "id": "prod-semax",
  "sources": [],
  "suppliers": [],
  "communityReports": [],
  "expertOpinions": [],
  "lastUpdated": "2026-02-04T14:50:14.777Z",
  "createdAt": "2026-02-04T14:50:14.777Z"
}